Back to News
Market Impact: 0.7

European shares hit record high as tech stocks flourish, healthcare rally continues

ASMLPFERACEHSBCSMCIAPPGOOGLGOOG
Market Technicals & FlowsTechnology & InnovationArtificial IntelligenceHealthcare & BiotechAutomotive & EVAnalyst InsightsEconomic DataElections & Domestic Politics
European shares hit record high as tech stocks flourish, healthcare rally continues

European equities, led by the STOXX 600 index, surged to an intraday record high on Thursday, gaining 0.7%. This rally was primarily driven by strong performance in chip-related companies, buoyed by an overnight Wall Street rally and new supply deals for OpenAI, alongside continued momentum in healthcare stocks following a U.S.-Pfizer agreement and a boost in auto stocks. Investors are also monitoring developments regarding a potential U.S. government shutdown, which could delay crucial jobs data.

Analysis

European equities, exemplified by the pan-European STOXX 600 index gaining 0.7% to a record high of 568.5, are experiencing a broad-based rally with strong leadership from the technology sector. Technology stocks surged 2.3%, directly benefiting from positive sentiment spilling over from Wall Street and a significant fundamental catalyst: Samsung and SK Hynix signing letters of intent to supply memory chips for OpenAI's data centers. This AI-driven demand directly boosted European semiconductor equipment manufacturers, with ASML and ASMI shares jumping over 4% each. The rally is supported by other key sectors, including healthcare, which rose 1% continuing momentum from a U.S.-Pfizer deal that reduced sector uncertainty, and the autos sector, which climbed 2.1% on a company-specific catalyst of HSBC upgrading Ferrari to "buy," causing its stock to gain 3.2%. A key near-term macro risk remains the potential U.S. government shutdown, which threatens to delay the release of crucial U.S. jobs data and could introduce market volatility.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo